Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy

Immunoglobulin replacement therapy is a mainstay therapy for patients with primary immunodeficiency (PID). The content of these preparations was studied extensively. Nevertheless, data regarding the effective specific antibodies content (especially in the nadir period), and, in different groups of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassin, Ori, Abu Freih, Yahya, Hazan, Ran, Lev, Atar, Zrihen, Keren S., Somech, Raz, Broides, Arnon, Nahum, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915625/
https://www.ncbi.nlm.nih.gov/pubmed/33557365
http://dx.doi.org/10.3390/jcm10040592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915625/
https://www.ncbi.nlm.nih.gov/pubmed/33557365
http://dx.doi.org/10.3390/jcm10040592

Ejemplares similares